Bioinspired chitosan based functionalization of biomedical implant surfaces for enhanced hemocompatibility, antioxidation and anticoagulation potential: an in silico and in vitro study

• Published in: RSC advances Vol. 14; no. 29; pp. 20691 - 20713
• Main Authors: Hassan, Sadia, Bilal, Namra, Khan, Tooba Javaid, Ali, Murtaza Najabat, Ghafoor, Bakhtawar, Saif, Khawaja Usman
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 27-06-2024; The Royal Society of Chemistry
• Subjects: Anticoagulants; Biocompatibility; Biomedical materials; Blood coagulation; Chemistry; Chitosan; Clotting; Composition; Drugs; Fourier transforms; Heparin; Surgical implants; Sustained release; Thrombosis; Transplants & implants
• ISSN: 2046-2069; 2046-2069
• DOI: 10.1039/d4ra00796d

Endowing implanted biomaterials with better hemocompatibility, anticoagulation, antioxidant and antiplatelet adhesion is necessary because of their potential to trigger activation of multiple reactive mechanisms including coagulation cascade and potentially causing serious adverse clinical events like late thrombosis. Active ingredients from natural sources including
,
, and
have the ability to inhibit the coagulation cascade and thrombus formation around biomedical implants. These properties are of interest for the development of a novel drug for biomedical implants to potentially solve the current blood clotting and coagulation problems which lead to stent thrombosis. The objective of this study was to incorporate different anticoagulants from natural sources into a degradable matrix of chitosan with varying concentrations ranging from 5% to 15% and a composite containing all three drugs. The presence of anticoagulant constituents was identified using GC-MS. Subsequently, all the compositions were characterized principally by using Fourier transform infrared spectroscopy and scanning electron microscopy while the drug release profile was determined using UV-spectrometry for a 30 days immersion period. The results indicated an initial burst release which was subsequently followed by the sustained release pattern. Compared to heparin loaded chitosan, DPPH and hemolysis tests revealed better blood compatibility of natural drug loaded films. Moreover, the anticoagulation activity of natural drugs was equivalent to the heparin loaded film; however, through docking, the mechanism of inhibition of the coagulation cascade of the novel drug was found to be through blocking the extrinsic pathway. The study suggested that the proposed drug composite expresses an optimum composition which may be a practicable and appropriate candidate for biomedical implant coatings.